{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T17:39:07Z","timestamp":1765993147316},"reference-count":64,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.steroids.2014.01.010","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T02:46:00Z","timestamp":1391827560000},"page":"52-61","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation"],"prefix":"10.1016","volume":"83","author":[{"given":"Sarah Tamar","family":"Lancaster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Makishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyasu","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Peter","family":"Mansell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.steroids.2014.01.010_b0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.beem.2011.05.003","article-title":"Regulation of vitamin D metabolism","volume":"25","author":"Henry","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.steroids.2014.01.010_b0010","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1210\/endo.139.8.6185","article-title":"Editorial: 24,25-dihydroxyvitamin D \u2013 active metabolite or inactive catabolite?","volume":"139","author":"St-Arnaud","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.01.010_b0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0039-128X(00)00155-0","article-title":"24,25-Dihydroxyvitamin D3 and bone metabolism","volume":"66","author":"van Leeuwen","year":"2001","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.steroids.2014.01.010_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1615\/CritRevEukarGeneExpr.v17.i1.30","article-title":"Membrane receptors for vitamin D metabolites","volume":"17","author":"Khanal","year":"2007","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2014.01.010_b0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jsbmb.2010.03.012","article-title":"Interrelation of parathyroid hormone and vitamin D metabolites in adolescents from the UK and the Gambia","volume":"121","author":"Schoenmakers","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.steroids.2014.01.010_b0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11914-012-0098-z","article-title":"Vitamin D and bone","volume":"10","author":"Bikle","year":"2012","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"10.1016\/j.steroids.2014.01.010_b0315","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1210\/endo-119-4-1776","article-title":"1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation","volume":"119","author":"Beresford","year":"1986","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.steroids.2014.01.010_b0035","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/jbm.a.32596","article-title":"The role of phospholipase D in osteoblast response to titanium surface microstructure","volume":"93","author":"Fang","year":"2010","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.steroids.2014.01.010_b0040","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jbmr.5650051111","article-title":"Regulation of alkaline phosphatase by 1,25-dihydroxyvitamin D3 and ascorbic acid in bone-derived cells","volume":"5","author":"Franceschi","year":"1990","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.steroids.2014.01.010_b0045","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jbmr.5650090816","article-title":"Modulation of ecto-nucleoside triphosphate pyrophosphatase activity of human osteoblast-like bone cells by 1 alpha,25-dihydroxyvitamin D3, 24R,25-dihydroxyvitamin D3, parathyroid hormone, and dexamethasone","volume":"9","author":"Oyajobi","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.steroids.2014.01.010_b0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/joe.0.1050391","article-title":"Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro","volume":"105","author":"Skjodt","year":"1985","journal-title":"J Endocrinol"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2014.01.010_b0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2010.11.010","article-title":"Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line","volume":"123","author":"Somjen","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.steroids.2014.01.010_b0060","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.20875","article-title":"Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization","volume":"99","author":"van Driel","year":"2006","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/j.steroids.2014.01.010_b0320","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/excr.1998.4189","article-title":"24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells","volume":"244","author":"Yamamoto","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.steroids.2014.01.010_b0065","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/1381612043383818","article-title":"Osteoblast differentiation and control by vitamin D and vitamin D metabolites","volume":"10","author":"van Driel","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2014.01.010_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2004.04.005","article-title":"Epidermal growth factor and calcitriol synergistically induce osteoblast maturation","volume":"220","author":"Yarram","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2014.01.010_b0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.prostaglandins.2006.04.001","article-title":"Lysophosphatidic acid cooperates with 1\u03b1,25(OH)2D3 in stimulating human MG63 osteoblast maturation","volume":"80","author":"Gidley","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"10.1016\/j.steroids.2014.01.010_b0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biomaterials.2009.09.035","article-title":"The synergistic effects of lysophosphatidic acid receptor agonists and calcitriol on MG63 osteoblast maturation at titanium and hydroxyapatite surfaces","volume":"31","author":"Mansell","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.steroids.2014.01.010_b0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.22203\/eCM.v023a27","article-title":"Lysophosphatidic acid-functionalised titanium as a superior surface for supporting human osteoblast (MG63) maturation","volume":"23","author":"Mansell","year":"2012","journal-title":"Eur Cells Mater"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2014.01.010_b0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2009.02.032","article-title":"Cytoskeletal reorganisation, 1alpha,25-dihydroxy vitamin D3 and human MG63 osteoblast maturation","volume":"305","author":"Mansell","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.steroids.2014.01.010_b0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bone.2011.12.002","article-title":"The emerging role of lysophosphatidic acid (LPA) in skeletal biology","volume":"50","author":"Blackburn","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.steroids.2014.01.010_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbalip.2012.04.005","article-title":"Lysophosphatidic acid, human osteoblast formation, maturation and the role of 1alpha,25-dihydroxyvitamin D3 (calcitriol)","volume":"1831","author":"Mansell","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.steroids.2014.01.010_b0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/clp.12.86","article-title":"The role of lysophosphatidic acid on human osteoblast formation, maturation and the implications for bone health and disease","volume":"8","author":"Lancaster","year":"2013","journal-title":"Clin Lipidol"},{"issue":"13","key":"10.1016\/j.steroids.2014.01.010_b0110","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1016\/S0021-9258(19)50371-4","article-title":"Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63)","volume":"267","author":"Bonewald","year":"1992","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.steroids.2014.01.010_b0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0026-0495(92)90189-H","article-title":"Differentiation of normal human bone cells by transforming growth factor-\u03b2 and 1,25(OH)2 vitamin D3","volume":"41","author":"Wergedal","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.steroids.2014.01.010_b0120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","article-title":"Physiological role of alkaline phosphatase explored in hypophosphatasia","volume":"1192","author":"Whyte","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20134","key":"10.1016\/j.steroids.2014.01.010_b0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2011.05.003","article-title":"Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA","volume":"95","author":"Mansell","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.steroids.2014.01.010_b0130","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1021\/jo020729l","article-title":"Synthesis of monofluorinated analogues of lysophosphatidic acid","volume":"68","author":"Xu","year":"2003","journal-title":"J Org Chem"},{"key":"10.1016\/j.steroids.2014.01.010_b0135","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1021\/jm049186t","article-title":"Structure\u2013activity relationships of fluorinated lysophosphatidic acid analogues","volume":"48","author":"Xu","year":"2005","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.steroids.2014.01.010_b0140","doi-asserted-by":"crossref","first-page":"16506","DOI":"10.1074\/jbc.M910000199","article-title":"Antagonistic action of a 25-carboxylic ester analogue of 1alpha, 25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators","volume":"275","author":"Herdick","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.steroids.2014.01.010_b0145","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.64.4.994","article-title":"Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors","volume":"64","author":"Ohta","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"25","key":"10.1016\/j.steroids.2014.01.010_b0150","doi-asserted-by":"crossref","first-page":"17304","DOI":"10.1074\/jbc.M109.003194","article-title":"Unique ligand selectivity of the GPR92\/LPA5 lysophosphatidate receptor indicates role in human platelet activation","volume":"284","author":"Williams","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.steroids.2014.01.010_b0155","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bmc.2006.10.069","article-title":"Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position","volume":"15","author":"Kobayashi","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.steroids.2014.01.010_b0160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000225298","article-title":"In vitro cultivation of human tumour tissues II. Morphological and virological characterisation of three cell lines","volume":"35","author":"Heremans","year":"1978","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.steroids.2014.01.010_b0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/8756-3282(94)90305-0","article-title":"Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype?","volume":"15","author":"Clover","year":"1994","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.steroids.2014.01.010_b0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2012.222","article-title":"Assessment of 24,25(OH)(2)D levels does not support FGF23-mediated catabolism of vitamin D metabolites","volume":"82","author":"Dai","year":"2012","journal-title":"Kidney Int"},{"issue":"Suppl II)","key":"10.1016\/j.steroids.2014.01.010_b0175","doi-asserted-by":"crossref","first-page":"ii40","DOI":"10.1136\/ard.61.suppl_2.ii40","article-title":"Functions of AP1 (Fos\/Jun) in bone development","volume":"61","author":"Wagner","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.steroids.2014.01.010_b0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2008.02.030","article-title":"Transcription factors controlling osteoblastogenesis","volume":"473","author":"Marie","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.steroids.2014.01.010_b0185","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1083\/jcb.201002111","article-title":"Fra-2\/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production","volume":"190","author":"Bozec","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.steroids.2014.01.010_b0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/MCB.19.1.330","article-title":"The repertoire of Fos and Jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation","volume":"19","author":"Cook","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.steroids.2014.01.010_b0195","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.steroids.2009.07.005","article-title":"Lithocholate\u2013a promising non-calcaemic calcitriol surrogate for promoting human osteoblast maturation upon biomaterials","volume":"74","author":"Mansell","year":"2009","journal-title":"Steroids"},{"issue":"3\u20134","key":"10.1016\/j.steroids.2014.01.010_b0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0960-0760(96)00194-X","article-title":"In vitro binding of vitamin D receptor occupied by 24r,25-dihydroxyvitamin D3 to vitamin D responsive element of human osteocalcin gene","volume":"60","author":"Uchida","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"10.1016\/j.steroids.2014.01.010_b0205","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1016\/S0021-9258(19)43754-X","article-title":"The biological activity and metabolism of 24,25-dihydroxyvitamin D3","volume":"248","author":"Boyle","year":"1973","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.steroids.2014.01.010_b0210","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/bi00748a007","article-title":"24,25-Dihydroxyvitamin D3. Synthesis and biological activity","volume":"12","author":"Lam","year":"1973","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.steroids.2014.01.010_b0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02555140","article-title":"Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3","volume":"43","author":"Nakamura","year":"1988","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.steroids.2014.01.010_b0220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/276517a0","article-title":"24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation","volume":"276","author":"Ornoy","year":"1978","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.steroids.2014.01.010_b0225","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1359\/jbmr.1997.12.4.598","article-title":"Three-fold induction of renal 25-hydroxyvitamin D3\u201324-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture","volume":"12","author":"Seo","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.steroids.2014.01.010_b0230","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/endo.138.9.5398","article-title":"24R,25-Dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks","volume":"138","author":"Seo","year":"1997","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.steroids.2014.01.010_b0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.steroids.2011.11.007","article-title":"Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase","volume":"77","author":"Chiellini","year":"2012","journal-title":"Steroids"},{"issue":"14","key":"10.1016\/j.steroids.2014.01.010_b0240","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1016\/j.bmcl.2008.06.018","article-title":"Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR)","volume":"18","author":"Das","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.steroids.2014.01.010_b0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/toxsci\/kfj173","article-title":"Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system","volume":"91","author":"Lemaire","year":"2006","journal-title":"Toxicol Sci"},{"issue":"10","key":"10.1016\/j.steroids.2014.01.010_b0250","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/S0021-9258(19)42632-X","article-title":"Mitochondrial cytochrome P450 a component of chick kidney 25-hydroxycholecalciferol-1alpha-hydroxylase","volume":"249","author":"Ghazarian","year":"1974","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.steroids.2014.01.010_b0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000343104","article-title":"The history of the discovery of vitamin D and its daughter steroid hormone","volume":"61","author":"Norman","year":"2012","journal-title":"Ann Nutr Metab"},{"issue":"15","key":"10.1016\/j.steroids.2014.01.010_b0260","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1016\/S0021-9258(18)43337-6","article-title":"Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3","volume":"256","author":"Howard","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2014.01.010_b0265","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/bi00274a012","article-title":"Calvarial cells synthesize 1alpha,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3","volume":"22","author":"Turner","year":"1983","journal-title":"Biochemistry"},{"issue":"13","key":"10.1016\/j.steroids.2014.01.010_b0270","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1096\/fj.06-6374fje","article-title":"Evidence for auto\/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells","volume":"20","author":"van Driel","year":"2006","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.steroids.2014.01.010_b0275","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","article-title":"The osteoblast: an insulin target cell controlling glucose homeostasis","volume":"26","author":"Clemens","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.steroids.2014.01.010_b0280","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00125-011-2155-z","article-title":"The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism","volume":"54","author":"Ducy","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.01.010_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06360.x","article-title":"A crosstalk between bone and gonads","volume":"1260","author":"Oury","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.steroids.2014.01.010_b0290","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF02409505","article-title":"Interaction between 24r,25-dihydroxycholecalciferol and 1,25-dihyroxycholecalciferol on 45Ca release from bone in vitro","volume":"33","author":"Mahgoub","year":"1981","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.steroids.2014.01.010_b0295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00298729","article-title":"Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells","volume":"52","author":"Yamato","year":"1993","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.steroids.2014.01.010_b0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jbmr.5650040205","article-title":"A direct effect of 24,25-(OH)2D3 and 1,25-(OH)2D3 on the modeling of fetal mice long bones in vitro","volume":"4","author":"Schwartz","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.steroids.2014.01.010_b0305","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2174\/1381612003400371","article-title":"Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation","volume":"6","author":"Hansen","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.steroids.2014.01.010_b0310","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.bjc.6600162","article-title":"A phase II trial of the vitamin D analogue seocalcitol (ED1089) in patients with inoperable pancreatic cancer","volume":"86","author":"Evans","year":"2002","journal-title":"Br J Cancer"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T03:00:17Z","timestamp":1716519617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":64,"alternative-id":["S0039128X14000208"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.01.010","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}